Xender to distribute 10,000 CyberCare systems
Xender to distribute 10,000 CyberCare systemsXender Corporation, a Taiwanese electronic instruments manufacturer, has signed a licensing agreement with CyberCare, a technology-based health management company, to manufacture, sell, and distribute
Xender to distribute 10,000 CyberCare systems
Xender Corporation, a Taiwanese electronic instruments manufacturer, has signed a licensing agreement with CyberCare, a technology-based health management company, to manufacture, sell, and distribute 10,000 CyberCare Electronic HouseCall systems over the next three years. Under terms of the deal, Xender will pay CyberCare a $500 per unit royalty fee to install, operate, and maintain the communications network in Taiwan and will receive a recurring network fee of $200 per month per installed unit.
Xender claims to have established relationships with more than 300 medical facilities in Taiwan and expects these customers to purchase the Electronic HouseCall system to enhance care for their chronically ill patients. The Electronic HouseCall is an Internet-based system for remote monitoring of patients.
- Search Again
- Return To HNN Homepage
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
